Product
VEN+AZA-5
1 clinical trial
1 indication
Indication
Acute Myeloid LeukemiaClinical trial
A Single-arm, Pilot Study of Venetoclax in Combination With 5 Days Azacitidine in Treatment-naïve Subjects With Acute Myelogenous Leukemia Who Are ≥18 Years of Age and Not Eligible for Standard Induction Therapy (VENAZA-5S PILOT TRIAL)Status: Recruiting, Estimated PCD: 2025-01-01